Outset Medical (OM) Income from Continuing Operations (2019 - 2026)

Outset Medical (OM) has reported Income from Continuing Operations for 8 consecutive years, with -$18.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Income from Continuing Operations rose 3.0% year-over-year to -$18.0 million in Q2 2026; TTM through Jun 2026 was -$56.6 million, a 42.21% increase from a year earlier, with the FY2025 full-year figure at -$63.9 million, up 50.04% from the prior year.
• Income from Continuing Operations was -$18.0 million for Q2 2026 at Outset Medical, up from -$19.0 million in the prior quarter.
• Over five years, Income from Continuing Operations peaked at -$1.8 million in Q4 2025 and troughed at -$46.2 million in Q3 2023.
• A 5-year average of -$31.4 million and a median of -$35.7 million in 2022 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations plunged 45.12% in 2022 and jumped 93.07% in 2025, its largest moves.
• Over 5 years, Income from Continuing Operations stood at -$41.4 million in 2022, then climbed by 6.86% to -$38.6 million in 2023, then soared by 33.58% to -$25.6 million in 2024, then jumped by 93.07% to -$1.8 million in 2025, then sank by 912.61% to -$18.0 million in 2026.
• The last three Income from Continuing Operations figures came in at -$18.0 million (Q2 2026), -$19.0 million (Q1 2026), and -$1.8 million (Q4 2025), per Business Quant data.